Therefore, it is suggested that nesfatin-1 secretion may be inhibited by insulin resistance, hyperglycemia, hyperinsulinemia, or obesity, which could explain why nesfatin-1 levels are decreased in these conditions [75,77]. Here, NUCB2 is linked to Hyperinsulinemia.